 Pharmacologically, carzelesin proved to be relatively schedule and route independent and was highly active against i.p.implanted L1210 leukemia, regardless of whether the analogue was given i.v., i.p., s.c., or p.o.These results, collectively, suggest that carzelesin is absorbed and distributed well.